Top

BMC Immunology

Published in:

Open Access 01-12-2015 | Research article

Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin

Authors: Naiyana Gujral, Ju Won Suh, Hoon H. Sunwoo

Published in: BMC Immunology | Issue 1/2015

Abstract

Background

Pepsin-trypsin resistant gliadin (PT-gliadin) promotes intestinal tissue inflammation and increases paracellular permeability of immunogenic gliadin peptides into the lamina propria. This leads to the complications seen in the pathogenesis of celiac disease (CD). In this study, specific anti-gliadin IgY antibody was produced and evaluated for its efficacy on gliadin induced intestinal integrity impairment and proinflammatory effects on intestinal epithelial (Caco-2) cell culture model for CD.

Methods

Caco-2 (passages 20-24) monolayers were subjected to 7 experimental conditions (n=3 each): phosphatebufferedsaline (PBS; control), pancreatic digested-casein (PD-casein; negative control), PT-gliadin (positive control), non-specific IgY with PT-gliadin, and anti-wheat gliadin IgY with PT-gliadin at a ratio of 1:6,000, 1:3,000 and 1:1,500. Caco-2 monolayers were then evaluated for effects of gliadin and/or anti-wheat gliadin IgY after 24 h exposure. Enzyme-linked immunosorbent assay (ELISA) was used to quantify anti-inflammatory markers (TNF-α and IL-1β) 5 days after cells were exposed to PT-gliadin and/or anti-wheat gliadin IgY.

Results

Among other conditions, anti-wheat gliadin IgY at a ratio of 1:3,000 (anti-gliadin IgY: PT-gliadin) significantlyprevented gliadin toxicity on Caco-2 by maintaining intestinal integrity, inhibiting phenol red permeation, and inhibiting gliadin absorption and production of proinflammatory cytokines (TNF-α and IL-1β) as compared to PT-gliadin stimulated cultures (P < 0.05).

Conclusion

The anti-wheat gliadin IgY antibody produced in this study has proved to inhibit absorption of gliadin and gliadin-induced inflammatory response in Caco2 cell culture model of CD. Anti-gliadin IgY, therefore has potential to be used as an oral passive antibody therapy to treat CD.

Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of CD in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95.PubMedCrossRef

Marsh MN. Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterol. 1992;102:330–54.

Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480–93.PubMedCrossRef

Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–7.PubMedCrossRef

Laparra JM, Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem. 2010;109:801–7.PubMed

Barone MV, Nanayakkara M, Paolella G, Maglio M, Vitale V, Troiano R, et al. Gliadin peptide P31-43 localizes to endocytic vesicles and interferes with their maturation. PLoS One. 2010;5:12246.CrossRef

Zimmer KP, Fischer I, Mothes T, Weissen-Plenz G, Schmitz M, Wieser H, et al. Endocytotic segregation of gliadin peptide 31–49 in enterocytes. Gut. 2010;59:300–10.PubMedCrossRef

Molberg Ã, McAdam SN, KoÌˆrner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med. 1998;4:713–7.PubMedCrossRef

Harris KM, Fasano A, Mann DL. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol. 2008;181:4457–60.PubMedCrossRef

10.

Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, et al. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol. 2010;134:289–95.PubMedCrossRef

11.

Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vézina A, Rivard N, et al. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterol. 2009;136:288–98.CrossRef

12.

Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006;41:408–19.PubMedCrossRef

13.

Pardin C, Roy I, Lubell WD, Keillor JW. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase. Chem Biol Drug Design. 2008;72:189–96.CrossRef

14.

Anderson RP, Van Heel DA, Tye-Din JA, Keillor JW. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut. 2006;55:485–91.PubMedCentralPubMedCrossRef

15.

Hüe S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21:367–77.PubMedCrossRef

16.

Gujral N, Löbenberg R, Suresh M, Sunwoo HH. In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J Agri Food Chem. 2012;60:3166–72.CrossRef

17.

Reilly RM, Domingo R, Sandhu J. Oral delivery of antibodies. Future pharmacokinetic trends. Clin Pharmacokinetics. 1997;32:313–23.CrossRef

18.

Sarker SA, Casswall TH, Juneja LR, Hoq E, Hossain I, Fuchs GJ, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutrition. 2001;32:19–25.CrossRef

19.

Sunwoo HH, Lee EN, Menninen K, Suresh MR, Sim JS. Growth inhibitory effect of chicken egg yolk antibody (IgY) on Escherichia coli O157:H7. J Food Sci. 2002;67:1486–94.CrossRef

20.

Lee EN, Sunwoo HH, Menninen K, Sim JS. In vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidis and Salmonella typhimurium. Poultry Sci. 2002;81:632–41.CrossRef

21.

Song MS, Kim CJ, Cho WI, Sunwoo HH. Growth inhibition of clostridium perfringens vegetative cells and spores using chicken immunoglobulin Y. J Food Safety. 2009;29:511–20.CrossRef

22.

Lindfors K, Rauhavirta T, Stenman S, Mäki M, Kaukinen K. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options. Experim Biol Med. 2012;237:119–25.CrossRef

23.

Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M. Induction of apoptosis in Caco-2 cells by wheat gliadin peptides. Toxicol. 2000;145:63–71.CrossRef

24.

Giovannini C, Matarrese P, Scazzocchio B, Varí R, D’Archivio M, Straface E, et al. Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway. FEBS Letters. 2003;540:117–24.PubMedCrossRef

25.

Stenman SM, Venäläinen JI, Lindfors K, Auriola S, Mauriala T, Kaukovirta-Norja A, et al. Enzymatic detoxification of gluten by germinating wheat proteases: Implications for new treatment of celiac disease. Ann Med. 2009;41:390–400.PubMedCrossRef

26.

Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–9.PubMedCrossRef

27.

Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J of Phys - Gastrointestinal Liver Phys. 2002;283:996–1003.

28.

Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol. 2010;3:247–59.PubMedCrossRef

29.

Sunwoo HH, Lee EN, Gujral N, Suresh MR. Growth inhibition of Escherichia coli 987P by neutralizing IgY antibodies. Open Immunol J. 2010;3:1–8.CrossRef

30.

Gujral N, Loebenberg R, Suresh M, Sunwoo HH. In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J Agricul Food Chem. 2012;60:3166–72.CrossRef

31.

Gujral N, Suresh MR, Sunwoo HH. Quantitative double antibody sandwich ELISA for the determination of gliadin. J Immunoassay Immunochem. 2012;33:339–51.PubMedCrossRef

32.

Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem. 1993;57:450–4.PubMedCrossRef

33.

Sim JS, Sunwoo HH, Lee EN, Ovoglobulin Y. In: Naidu AS, editor. Natural food antimicrobial systems. New York: CRC Press; 2000. p. 227–52.

34.

Fina D, Sarra M, Caruso R, Del Vecchio BG, Pallone F, MacDonald TT, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut. 2008;57:887–92.PubMedCrossRef

35.

Carroccio A, Iacono G, D’Amico D, Cavataio F, Teresi S, Caruso C, et al. Production of anti-endomysial antibodies in cultured duodenal mucosa: Usefulness in coeliac disease diagnosis. Scand J Gastroenterol. 2002;37:32–8.PubMedCrossRef

36.

Vogelsang H, Schwarzenhofer M, Granditsch G, Oberhuber G. In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease. Am J Gastroenterol. 1999;94:1057–61.PubMedCrossRef

37.

Henderson B, Wilson M, McNab R, Lax AJ. The innate immune response. In: Cell Microbio. Chichester: Wiley; 1999. p. 311–53.

38.

Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature Rev Gastroenterol Hepatol. 2000;406:782–7.

39.

Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol. 2000;164:966–72.PubMedCrossRef

40.

Lübbing N, Barone MV, Rudloff S, Troncone R, Auricchio S, Zimmer KP. Correction of gliadin transport within enterocytes through celiac disease serum. Pediatr Res. 2011;70:357–62.PubMedCrossRef

41.

Li N, DeMarco VG, West CM, Neu J. Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells. J Nutri Biochem. 2003;14:401–8.CrossRef

42.

Chiara M, DeStefano D, Mele G, Fecarotta S, Greco L, Troncone R. Nuclear factor kB is activated in small intestinal mucosa of celiac patients. J Mol Med. 2003;81:373–9.

43.

Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, et al. Per Brandtzaeg Gluten induces an intestinal cytokine response strongly dominated by interferon γ in patients with celiac disease. Gastroenterol. 1998;115:551–63.CrossRef

44.

Beckett CG, Dell’Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Europ J Gastroenterol Hepatol. 1999;11:529–35.CrossRef

45.

Jelínková L, Tucková L, Cinová J, Flegelová Z, Tlaskalová-Hogenová H. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Letters. 2004;571:81–5.PubMedCrossRef

46.

Helms S. Celiac disease and gluten-associated diseases. Alt Med Rev. 2005;10:172–92.

47.

Hoffman RA. Intraepithelial lymphocytes coinduce nitric oxide synthase in intestinal epithelial cells. Am J of Phys - Gastrointestinal Liver Phys. 2000;278:G886–94.

48.

Natoli M, Leoni BD, D’Agnano I, Zucco F, Felsani A. Good Caco-2 cell culture practices. Toxicol In Vitro. 2012;26:1243–46.PubMedCrossRef

49.

Ferruzza S, Scarino ML, Gambling L, Natella F, Sambuy Y. Biphasic effect of iron on human intestinal Caco-2 cells: early effect on tight junction permeability with delayed onset of oxidative cytotoxic damage. Cell Mol Biol. 2003;49:89–99.PubMed

Title: Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin
Authors: Naiyana Gujral
Ju Won Suh
Hoon H. Sunwoo
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Immunology / Issue 1/2015
Electronic ISSN: 1471-2172
DOI: https://doi.org/10.1186/s12865-015-0104-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Association between cytokine gene polymorphisms and tuberculosis in a Chinese population in Shanghai: a case–control study

Current challenges in understanding immune cell functions during septic syndromes

Multi-layered epigenetic mechanisms contribute to transcriptional memory in T lymphocytes

Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B

Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5+ B cell expansion

Elevated levels of dehydroepiandrosterone as a potential mechanism of dendritic cell impairment during pregnancy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page